Medarex (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- January 15, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Founding Year
- 1997
- Traction
- Medarex has successfully completed multiple clinical trials and has partnerships with leading pharmaceutical companies.
- Revenue Amount
- $10,000,000
- ARR
- $5,000,000
- Founders
- David M. Johnson, Sarah L. Smith
- Company Description
- Medarex is a biotechnology company focused on developing innovative therapeutic products for the treatment of cancer and other diseases. The company utilizes its proprietary technology platform to create monoclonal antibodies and other biologics.
- Market
- Healthcare
- Location
- Princeton, New Jersey, USA